rTMS & Ketamine Treatment Resistant Depression
Join us for an insightful discussion on treatment-resistant depression with Dr. Ahmed Saleh, MD, FRCPC, Co-founder, and Medical Director at ANSR Clinic. Treatment-resistant depression poses significant challenges in mental health care, prompting ongoing research into newer treatment options to enhance the quality of life for patients facing this disorder. In this webinar, we will explore two innovative treatment modalities: Ketamine and rTMS (Repetitive Transcranial Magnetic Stimulation). Both have emerged as potential solutions for treatment-resistant depression, with ongoing research aimed at understanding their benefits comprehensively. Ketamine, in particular, shows promise not only for depression but also for conditions like bipolar depression, PTSD, and OCD. Join Dr. Ahmed Saleh on Thursday, November 17, between 12-1pm EST, as he delves into the nuances of treatment-resistant depression and discusses the potential programming options available. LEARNING OBJECTIVES: Define and comprehend treatment-resistant depression. Review the efficacy of rTMS in depression treatment. Explore the potential benefits of ketamine in depression treatment. Discuss the off-label use of rTMS and ketamine in mental health care. Webinar with timestamps: 0:12 - Introduction and Overview Jeremy introduces the session and EHN Canada, outlining the services and locations of their treatment facilities. 0:38 - Webinar Logistics Explanation of webinar logistics, noting that the session is recorded and participants' cameras and mics are off. 1:23 - Land Acknowledgment Jeremy acknowledges the traditional territories in Toronto and Halifax, encouraging participants to recognize the lands they are on. 2:10 - Session Topic Introduction Introduction to today's topic on RTMS and ketamine for treatment-resistant depression, setting the stage for the detailed discussion to follow. 3:18 - Speaker Introduction: Dr. Ahmed SLE Introduction of Dr. Ahmed SLE, highlighting his credentials and roles within the psychiatric community. 3:39 - Overview of RTMS and Ketamine Dr. SLE begins discussing the exciting potential of RTMS and ketamine in treating psychiatric disorders, particularly focusing on treatment-resistant depression. 4:06 - Detailed Discussion on Ketamine Dr. SLE provides a thorough overview of ketamine, including its history, properties, and its emerging role in psychiatric treatment. 8:24 - Efficacy of Ketamine Discussion on the efficacy of ketamine in treating treatment-resistant depression and its rapid action compared to traditional antidepressants. 14:03 - Introduction to RTMS Transition to discussing RTMS, explaining the technology, its applications, and its targeted approach in treating various mental health issues. 20:18 - Efficacy of RTMS Details on the effectiveness of RTMS in treating depression and other psychiatric conditions, supported by clinical evidence. 28:05 - Q&A Session Opening of the Q&A session, addressing participant questions on the applications, effectiveness, and specifics of RTMS and ketamine treatments. 57:20 - Closing Remarks and Upcoming Events
